Louise V. O'KEefe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Louise V. O'KEefe has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Choo
School of Biological Sciences, The University of Adelaide, Adelaide, Australia
2 shared publications - Cheng Shoou Lee
Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, SA 5000, Australia
1 shared publication Dani L. Webber
Department of Genetics and Evolution, School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia
1 shared publicationJohn J. Hopwood
Hopwood Centre for Neurobiology, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia
1 shared publication- Kim M. Hemsley
Flinders University
1 shared publication Laura J. Hewson
Department of Genetics and Evolution, School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia
1 shared publication
Latest Publications
- Open Access
Molecular Biology of the WWOX Gene That Spans Chromosomal Fragile Site FRA16D
It is now more than 20 years since the FRA16D common chromosomal fragile site was characterised and the WWOX gene spanning this site was identified. In this time, much information has been discovered about its contribution to disease; however, the normal biological role of WWOX is not yet clear. Experiments leading to the identification of the WWOX gene are recounted, revealing enigmatic relationships between the fragile site, its gene and the encoded protein. We also highlight research mainly using the genetically tractable model organism Drosophila melanogaster that has shed light on the integral role of WWOX in metabolism. In addition to this role, there are some particularly outstanding questions that remain regarding WWOX, its gene and its chromosomal location. This review, therefore, also aims to highlight two unanswered questions. Firstly, what is the biological relationship between the WWOX gene and the FRA16D common chromosomal fragile site that is located within one of its very large introns? Secondly, what is the actual substrate and product of the WWOX enzyme activity? It is likely that understanding the normal role of WWOX and its relationship to chromosomal fragility are necessary in order to understand how the perturbation of these normal roles results in disease.
Open AccessMolecular Biology of the WWOX Gene That Spans Chromosomal Fragile Site FRA16D
It is now more than 20 years since the FRA16D common chromosomal fragile site was characterised and the WWOX gene spanning this site was identified. In this time, much information has been discovered about its contribution to disease; however, the normal biological role of WWOX is not yet clear. Experiments leading to the identification of the WWOX gene are recounted, revealing enigmatic relationships between the fragile site, its gene and the encoded protein. We also highlight research mainly using the genetically tractable model organism Drosophila melanogaster that has shed light on the integral role of WWOX in metabolism. In addition to this role, there are some particularly outstanding questions that remain regarding WWOX, its gene and its chromosomal location. This review, therefore, also aims to highlight two unanswered questions. Firstly, what is the biological relationship between the WWOX gene and the FRA16D common chromosomal fragile site that is located within one of its very large introns? Secondly, what is the actual substrate and product of the WWOX enzyme activity? It is likely that understanding the normal role of WWOX and its relationship to chromosomal fragility are necessary in order to understand how the perturbation of these normal roles results in disease.
- 1 May 2018
- Published by Elsevier in Experimental Neurology
- Vol. 303, 38-47
Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA
- 1 May 2018
- Published by Elsevier in Experimental Neurology
- Vol. 303, 38-47
Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA